Pegfilgrastim BS subcutaneous injection 3.6mg “Nipro” by Mochida Pharmaceutical Sales contains Pegfilgrastim (genetical recombination) [Pegfilgrastim successor 1]. This injectable drug, YJ code 3399416G1028, is supplied as 3.6mg in 0.36mL per bottle and is used to prevent febrile neutropenia in patients receiving cancer chemotherapy.
Pegfilgrastim BS subcutaneous injection 3.6mg “Nipro”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
More from this manufacturer
